|
CDC73 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.30259971884573E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.41919842333982E-11 |
| Normal-vs-Stage2 |
1.004500E-03 |
| Normal-vs-Stage3 |
2.585400E-01 |
| Normal-vs-Stage4 |
4.619000E-01 |
| Stage1-vs-Stage2 |
6.199000E-01 |
| Stage1-vs-Stage3 |
2.660100E-03 |
| Stage1-vs-Stage4 |
5.890000E-02 |
| Stage2-vs-Stage3 |
8.594400E-02 |
| Stage2-vs-Stage4 |
2.050400E-01 |
| Stage3-vs-Stage4 |
9.415400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.85569950703768E-10 |
| Normal-vs-AfricanAmerican |
2.12939999999495E-06 |
| Normal-vs-Asian |
1.114380E-01 |
| Caucasian-vs-AfricanAmerican |
8.413400E-01 |
| Caucasian-vs-Asian |
9.979200E-01 |
| AfricanAmerican-vs-Asian |
9.454200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.45634632026304E-12 |
| Normal-vs-Female |
4.234300E-02 |
| Male-vs-Female |
8.35500000000433E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.239500E-04 |
| Normal-vs-Extreme_Weight |
5.16442444364884E-12 |
| Normal-vs-Obese |
1.060290E-03 |
| Normal-vs-Extreme_Obese |
2.958400E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.335350E-01 |
| Normal_Weight-vs-Obese |
5.487600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.340200E-01 |
| Extreme_Weight-vs-Obese |
1.421520E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.981200E-01 |
| Obese-vs-Extreme_Obese |
2.522600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.776800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.70300000054991E-07 |
| Normal-vs-Age(61-80Yrs) |
4.41310321619426E-11 |
| Normal-vs-Age(81-100Yrs) |
4.194699998461E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.229800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.226140E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.510200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.504100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.181900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.211000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.61775062632341E-12 |
| Normal-VS-Type2 PRCC |
1.563700E-04 |
| Normal-VS-KIRP CIMP |
5.229800E-01 |
| Normal-VS-Unclassified PRCC |
8.848200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.058400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.487700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.992400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.634410E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.282800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.700400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.30730001560664E-09 |
| Normal-vs-N1 |
6.939600E-01 |
| Normal-vs-N2 |
2.473800E-02 |
| N0-vs-N1 |
1.495970E-03 |
| N0-vs-N2 |
4.650600E-01 |
| N1-vs-N2 |
3.018800E-01 |
|
|
